M. Werner-Wasik

发表

Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study

T. Julian, T. George, R. Paulus, 2022, JMIR cancer.

Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in patients with newly diagnosed glioblastoma (GBM).

K. Aldape, D. Brachman, P. Brown, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

malities were within the target volume versus patients whose meta- bolic abnormalities extended beyond the treatment volume.

D. Andrews, S. Fogh, J. Clarke, 2011 .

A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.

W. Curran, D. Andrews, B. Downes, 1999, International journal of radiation oncology, biology, physics.

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

K. Aldape, W. Curran, D. Brachman, 2014, The New England journal of medicine.

Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy.

W. Curran, W. Hauck, R. Axelrod, 2002, Seminars in radiation oncology.

Conservatively Managed Chronic Bronchopleural Fistula After Lung Cancer Tri-Modality Therapy: A Case Report

N. Evans, C. Fernandez, Nilanjan Haldar, 2021, Advances in radiation oncology.

Estimation of the a / b ratio of non-small cell lung cancer treated with stereotactic body radiotherapy

H. Eich, R. Sweeney, J. Sonke, 2019 .

Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.

H. Eich, R. Sweeney, J. Sonke, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Occult nodal metastasis in non-small-cell lung cancer: implications for the radiation oncologist.

N. Ohri, B. Lu, M. Werner-Wasik, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).

M. Mehta, R. Valicenti, D. Andrews, 2013, International journal of radiation oncology, biology, physics.

A phase II study of a temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas: Preliminary results of RTOG 0424.

D. Brachman, M. Mehta, B. Fisher, 2013 .

Natural Antitumor Defense System of the Murine Liver

J. Nolan, M. Werner-Wasik, S. Cohen, 1985, Journal of leukocyte biology.

A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): A report of the 2 year and median survival (MS) for the RTOG 0324 trial

W. Curran, H. Choy, R. Komaki, 2008 .

Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?

J. Sonke, D. Yan, L. Kestin, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Esophagitis, treatment-related toxicity in non-small cell lung cancer.

V. Bar-ad, N. Ohri, M. Werner-Wasik, 2012, Reviews on recent clinical trials.

Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group

J. Sonke, A. Hope, M. Werner-wasik, 2017, Clinical lung cancer.

Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.

H. Eich, R. Sweeney, J. Sonke, 2020, International journal of radiation oncology, biology, physics.

Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.

J. Sonke, A. Hope, M. Werner-wasik, 2017, International journal of radiation oncology, biology, physics.

Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance

J. Sonke, D. Yan, L. Kestin, 2010 .

Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.

J. Sonke, A. Hope, M. Werner-wasik, 2019, International journal of radiation oncology, biology, physics.

Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of radiation therapy oncology group phase III study 95–08

W. Curran, M. Schell, L. Gaspar, 2002 .

Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: a multi-institutional phase II trial

D. Brachman, M. Mehta, R. Timmerman, 2011, Journal of Neuro-Oncology.

Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.

Jan-Jakob Sonke, Ying Xiao, Maria Werner-Wasik, 2012, International journal of radiation oncology, biology, physics.

Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance

J. Sonke, D. Yan, L. Kestin, 2010 .

Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.

Jan-Jakob Sonke, Maria Werner-Wasik, Matthias Guckenberger, 2016, International journal of radiation oncology, biology, physics.

In response to Drs. Vordermark and Kölbl

P. Okunieff, W. Curran, D. Brachman, 2005 .

Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-small Cell Lung Cancer (NSCLC)

J. Sonke, D. Yan, L. Kestin, 2010 .

Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.

J. Fowler, P. Gerszten, Lijun Ma, 2012, International journal of radiation oncology, biology, physics.

In reply [6]

B. Movsas, Colum J Smith, C. Langer, 2005 .

Clinical applications of radioprotectors

M. Werner-Wasik, 2001, Expert review of anticancer therapy.

Treatment-related esophagitis.

M. Werner-Wasik, 2005, Seminars in oncology.

A multinational pooled analysis of 434 cases of stage I non-small cell lung cancer (NSCLC) treated with volumetrically image-guided (VIGRT) stereotactic lung radiotherapy (SBRT): Results from the Elekta Collaborative Lung Research Group.

J. Sonke, D. Yan, L. Kestin, 2010 .

Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer.

J. Galvin, D. Michalski, C. Houser, 2002, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Cicatricial alopecia secondary to radiation therapy: case report and review of the literature.

T. Griffin, M. Werner-Wasik, Gregg A Severs, 2008, Cutis.

Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.

W. Curran, A. Dicker, D. Andrews, 2009, International journal of radiation oncology, biology, physics.

RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM).

K. Aldape, M. Gilbert, M. Mehta, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose-rate surface brachytherapy to boost elongated, curvilinear incisional scars after extrapleural pneumonectomy for malignant pleural mesothelioma treated with adjuvant intensity-modulated radiation therapy.

Yan Yu, T. Showalter, Ying Xiao, 2010, Brachytherapy.

Phase I study of irinotecan (Ir) and cisplatin (DDP) in combination with thoracic radiotherapy (RT), either twice daily (45 Gy) or once daily (70 Gy), in patients with limited (Ltd) small cell lung carcinoma (SCLC): Early analysis of RTOG 0241.

W. Curran, H. Choy, S. Swann, 2006, Journal of Clinical Oncology.

Hypofractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer-Does Size Matter?

N. Ohri, M. Werner-Wasik, 2022, JAMA oncology.

Stereotactic radiotherapy for trigeminal schwannomas.

James J. Evans, D. Andrews, W. Shi, 2012, Neurosurgery.

B. Leiby, Yunfeng Cui, M. Witek, 2014, American journal of clinical oncology.

Radiation dose-volume effects in the esophagus.

Joseph O. Deasy, Maria Werner-Wasik, Lawrence B. Marks, 2010, International journal of radiation oncology, biology, physics.

Trental (pentoxifylline) relieves pain from postradiation fibrosis.

H. Madoc‐Jones, M. Werner-Wasik, 1993, International journal of radiation oncology, biology, physics.

Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.

James J. Evans, D. Andrews, K. Judy, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial

K. Aldape, M. Mehta, B. Fisher, 2018, JAMA oncology.

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813

Susan M. Chang, K. Aldape, D. Brachman, 2016, Neuro-oncology.

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

James J. Evans, D. Andrews, M. Werner-wasik, 2014, Journal of Neuro-Oncology.

Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma

K. Aldape, M. Mehta, B. Fisher, 2021, JCO precision oncology.

Initial reporting of NRG-LU001 (NCT02186847), randomized phase II trial of concurrent chemoradiotherapy (CRT) +/- metformin in locally advanced Non-Small Cell Lung Cancer (NSCLC).

J. Bradley, J. Erasmus, Richard J Lee, 2019, Journal of Clinical Oncology.

Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.

H. Choy, B. Movsas, A. Sun, 2013, International journal of radiation oncology, biology, physics.

Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.

W. Curran, W. Hauck, M. Werner-wasik, 2000, International journal of radiation oncology, biology, physics.

Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial

R. Castillo, E. Castillo, T. Guerrero, 2022, Advances in radiation oncology.

A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.

Meihua Wang, M. Mehta, M. Schell, 2013, International journal of radiation oncology, biology, physics.

Predictors of radiation oncology resident research productivity.

A. Dicker, Y. Lawrence, R. Den, 2013, Journal of the American College of Radiology : JACR.

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of high-risk CT features for detection of local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer

J. Sonke, A. Hope, I. Grills, 2022 .

Reirradiation of recurrent meningioma

James J. Evans, A. Dicker, D. Andrews, 2012, Journal of Clinical Neuroscience.

Spheno-Orbital Meningiomas: An Analysis Based on World Health Organization Classification and Ki-67 Proliferative Index.

James J. Evans, D. Andrews, M. Curtis, 2017, Ophthalmic plastic and reconstructive surgery.

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing.

T. Hyslop, N. Flomenberg, B. Mookerjee, 2011, Blood.

Reirradiation for Recurrent Meningioma

James J. Evans, D. Andrews, A. Wojcieszynski, 2010 .

Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.

W. Curran, M. Werner-wasik, K. Fallon, 2005, International journal of radiation oncology, biology, physics.

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive‐Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

R. Hales, P. Iyengar, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.

James J. Evans, T. Olencki, A. Dicker, 2016, International journal of radiation oncology, biology, physics.

Neutrophil to lymphocyte ratio associated with prognosis of lung cancer

M. Werner-wasik, V. Bar-ad, R. Myers, 2017, Clinical and Translational Oncology.

STEREOTACTIC RADIOSURGERY AND FRACTIONATED STEREOTACTIC RADIOTHERAPY FOR THE TREATMENT OF NONACOUSTIC CRANIAL NERVE SCHWANNOMAS

T. Showalter, D. Andrews, W. Curran, 2008, Neurosurgery.

Improving prognosis of glioblastoma in the 21st century: Who has benefited most?

A. Dicker, T. Showalter, Y. Lawrence, 2012, Cancer.

Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.

J. Sonke, D. Yan, L. Kestin, 2012, International journal of radiation oncology, biology, physics.

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas

James J. Evans, N. Simone, A. Dicker, 2016, Journal of Neuro-Oncology.

The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation

M. Werner-wasik, R. Klement, C. Champ, 2018, Front. Oncol..

Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution.

W. Curran, D. Andrews, G. Bednarz, 2001, International journal of radiation oncology, biology, physics.

ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK

Nicholas G Zaorsky, A. Dicker, N. Giacalone, 2013, Molecular Cancer Therapeutics.

ALK Inhibitor PF 02341066 ( Crizotinib ) Increases Sensitivity to Radiation in Non – Small Cell Lung Cancer Expressing EML 4-ALK

Nicholas G Zaorsky, A. Dicker, N. Giacalone, 2013 .

Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation.

James J. Evans, D. Andrews, M. Downes, 2013, Neurosurgery.

Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts.

James J. Evans, S. Paek, M. Maltenfort, 2009, International journal of radiation oncology, biology, physics.

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

M. Mehta, P. Wen, H. Shih, 2018, Neuro-oncology.

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02

D. Nelson, L. Gaspar, W. Curran, 1996, Cancer.

Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution.

D. Andrews, G. Bednarz, M. Downes, 2005, International journal of radiation oncology, biology, physics.

A comparison of treatment outcomes with Gamma Knife radiosurgery versus Glycerol Rhizotomy in the management of trigeminal neuralgia

W. Curran, D. Andrews, R. Rosenwasser, 2003 .

Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.

Maria Werner-Wasik, Walter J Curran, W. Curran, 2011, Clinical lung cancer.

Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.

Adam P Dicker, Maria Werner-Wasik, Yaacov Richard Lawrence, 2008, Future oncology.

Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk.

L. Marks, T. Schultheiss, M. Werner-wasik, 2004, Hematology/oncology clinics of North America.

Immediate side effects of stereotactic radiotherapy and radiosurgery.

W. Hauck, D. Andrews, B. Downes, 1999, International journal of radiation oncology, biology, physics.

Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

R. Komaki, B. Movsas, Colum J Smith, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

Maria Werner-Wasik, Walter J Curran, Jean-Paul Bahary, 2004, The Lancet.

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).

M. Gilbert, M. Mehta, J. Knisely, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.

H. Choy, R. Komaki, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife

Yan Yu, Maria Werner-Wasik, David W. Andrews, 2016, Front. Oncol..

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.

D. Brat, M. Mehta, B. Fisher, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better

James J. Evans, D. Andrews, V. Bar-ad, 2015, Journal of Neuro-Oncology.

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.

Adam P Dicker, Maria Werner-Wasik, Terry Hyslop, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

S. Coons, D. Brachman, M. Mehta, 2015, International journal of radiation oncology, biology, physics.

Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.

Maria Werner-Wasik, Tito R Mendoza, Corneel Coens, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of Early Death in Patients with Early‐Stage NSCLC—Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach?

J. Sonke, A. Hope, I. Grills, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

K. Rosenzweig, W. Curran, H. Choy, 2015, Practical radiation oncology.

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.

Maria Werner-Wasik, Lucia Zamorano, Walter J Curran, 2004, International journal of radiation oncology, biology, physics.

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes

W. Curran, D. Brachman, P. Brown, 2019, Neurosurgery.

Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer

J. M. Michalski, Maria Werner-Wasik, J. D. Bradley, 2014 .

Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic

Steven H. Lin, M. Edelman, J. Donington, 2020, Journal of Thoracic Oncology.

Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic

Steven H. Lin, M. Edelman, J. Donington, 2020 .

Prognostic factors in non-small cell lung cancer.

M. J. Solan, M. Werner-Wasik, 2003, Seminars in surgical oncology.

Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.

Jeffrey D Bradley, Fenghai Duan, Abass Alavi, 2015, Journal of the National Cancer Institute.

Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.

Maria Werner-Wasik, Jeffrey Bradley, William Sause, 2008, International journal of radiation oncology, biology, physics.

Stereotactic body radiation therapy (SBRT) for patients with stage I non-small cell lung cancer is applicable to more tumors than sublobar resection

S. Cowan, B. Lu, N. Evans, 2018, Journal of thoracic disease.

Changes in the size and location of kidneys from the supine to standing positions and the implications for block placement during total body irradiation.

R. Valicenti, M. Huq, J. Reiff, 1999, International journal of radiation oncology, biology, physics.

Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients.

J. Sonke, A. Hope, I. Grills, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pilot study of carboplatin/radiotherapy plus 'dose-dense' pemetrexed for locally advanced non-small cell lung carcinoma

W. Curran, M. Machtay, P. Gilman, 2008 .

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial.

J. Bradley, J. Erasmus, R. Mcgarry, 2021, JAMA oncology.

Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer

C. Simone, V. Verma, M. Werner-Wasik, 2017, Cancers.

Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235

Jeffrey D Bradley, Issam El Naqa, Fenghai Duan, 2016, The Journal of Nuclear Medicine.

Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324.

W. Curran, H. Choy, R. Herbst, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer

C. Faivre-Finn, D. Cobben, C. Robinson, 2021, Frontiers in Oncology.

Preliminary report of RTOG 9508: A phase III trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastases

M. Schell, D. Andrews, W. Curran, 2000 .

Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

Benjamin Movsas, Maria Werner-Wasik, Nicos Nicolaou, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report

D. Andrews, S. Fogh, C. Glass, 2011, Journal of medical case reports.

Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma.

James J. Evans, P. Potrebko, D. Andrews, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.

H. Choy, L. Gaspar, K. Bae, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial

James J. Evans, H. Choy, A. Dicker, 2014, Journal of Neuro-Oncology.

Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma

D. Andrews, A. Flanders, K. Judy, 2021, Clinical Cancer Research.

Stereotactic Radiation Therapy in Primary Optic Nerve Sheath Meningioma

B. Jeremic, M. Buchgeister, G. Bednarz, 2008 .

Fractionated Stereotactic Radiotherapy for the Treatment of Optic Nerve Sheath Meningiomas: Preliminary Observations of 33 Optic Nerves in 30 Patients with Historical Comparison to Observation with or without Prior Surgery

W. Curran, C. Shields, R. Sergott, 2002, Neurosurgery.

Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.

S. Paek, D. Andrews, G. Bednarz, 2005, International journal of radiation oncology, biology, physics.

Characteristics of a dedicated linear accelerator-based stereotactic radiosurgery-radiotherapy unit.

B W Corn, M Werner-Wasik, W J Curran, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study

James J. Evans, R. Sergott, M. Witek, 2012, Radiation oncology.

Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.

W. Curran, B. Fisher, J. Bahary, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

D. Brachman, M. Mehta, J. Knisely, 2015, Journal of neurosurgery.

MRI changes due to early-delayed conformal radiotherapy and postsurgical effects in patients with brain tumors.

M. Shabbout, D. Hackney, J. Hunter, 2005, International journal of radiation oncology, biology, physics.

Hypofractionated Stereotactic Radiotherapy As Salvage Therapy For Recurrent Low-Grade Glioma Research Article

A. Dicker, D. Andrews, B. Downes, 2009 .

Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques.

Yan Yu, Ying Xiao, W. Shi, 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.

W. Curran, Meihua Wang, M. Mehta, 2019, International journal of radiation oncology, biology, physics.

Patterns of tumor progression after radiotherapy for low-grade gliomas: analysis from the computed tomography/magnetic resonance imaging era.

W. Curran, B. Corn, M. Werner-wasik, 1998, American journal of clinical oncology.

Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus

M. Mehta, A. Dicker, J. Palmer, 2018, Journal of Neuro-Oncology.

Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas

Maria Werner-Wasik, Wenyin Shi, D. Andrews, 2012, Radiation oncology.

Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma

D. Andrews, K. Judy, M. Werner-wasik, 2022, Frontiers in Oncology.

Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.

W. Curran, A. Dicker, D. Andrews, 2010, International journal of radiation oncology, biology, physics.

Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424.

M. Mehta, B. Fisher, D. D'Souza, 2020, International journal of radiation oncology, biology, physics.

Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma

James J. Evans, D. Andrews, K. Judy, 2020, Journal of Neuro-Oncology.

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database

D. Brachman, P. Brown, M. Gilbert, 2018, Neuro-oncology.

Low Non-Relapse Mortality after HLA Matched Related Two-Step Hematopoietic Stem Cell Transplantation using Cyclophosphamide (CY) for Graft versus Host Disease Prophylaxis and the Potential Impact of Non-CY-Exposed T Cells on Outcomes.

P. Porcu, U. Martinez-outschoorn, N. Flomenberg, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas.

Michael R. Green, K. Camphausen, T. Hyslop, 2013, International journal of radiation oncology, biology, physics.

EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324.

W. Curran, H. Choy, F. Hirsch, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.

H. Madoc‐Jones, M. Werner-wasik, C. Schmid, 1995, International journal of radiation oncology, biology, physics.

In Reply to Dr. Lacout et al.

Kristin D. Brockway, J. Piper, A. Nelson, 2012 .

Pathologic Correlation of PET-CT Based Auto Contouring for Radiation Planning in Lung Cancer

Maria Werner-Wasik, Shannon Fogh, Charles M. Intenzo, 2010 .

Clinical Prognostic Factors in Non-Small-Cell Lung Cancer

M. J. Solan, M. Werner-Wasik, 2006 .

Impact of Sarcopenia on Survival in Patients With Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy

B. Lu, V. Chen, James M. Taylor, 2020, Cureus.

Issues in nonoperative management of locally advanced non-small-cell lung cancer.

W. Curran, M. Werner-wasik, M. Werner-Wasik, 1998, Oncology.

Endogeneous interferon α/β produced by murine Kupffer cells augments liver-associated natural killing activity

J. Nolan, M. Werner-Wasik, S. Cohen, 2004, Cancer Immunology, Immunotherapy.

The American Society for Radiation Oncology's 2010 core physics curriculum for radiation oncology residents.

I. Chetty, J. Palta, B. Paliwal, 2011, International journal of radiation oncology, biology, physics.

Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school.

Nicholas G Zaorsky, A. Dicker, T. Showalter, 2012, International journal of radiation oncology, biology, physics.

Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study.

Nicholas G Zaorsky, A. Dicker, T. Showalter, 2013, International journal of radiation oncology, biology, physics.

Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

R. Komaki, B. Movsas, S. Swann, 2008, International journal of radiation oncology, biology, physics.

Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

James J. Evans, D. Andrews, E. Blomain, 2018, Journal of Neuro-Oncology.

Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.

P. Brown, M. Gilbert, M. Mehta, 2018, International journal of radiation oncology, biology, physics.

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

James J. Evans, D. Andrews, E. Blomain, 2018, Journal of Neuro-Oncology.

Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate.

C. Langlotz, P. Arger, T. Hyslop, 1997, Urology.

Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

K. Rosenzweig, W. Curran, H. Choy, 2015, Practical Radiation Oncology.

Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.

M Werner-Wasik, W. Curran, W. Hauck, 2001, International journal of radiation oncology, biology, physics.

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Robert Jeraj, Maria Werner-Wasik, Deborah T Blumenthal, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.

J. Bradley, R. Komaki, Y. Lawrence, 2013, Lung cancer.

Effect of Radiation Dose to Cardiac Substructures on the Acute Development of New Arrhythmias Following Conventionally Fractionated Radiation Treatment to the Lung

P. Lakhani, B. Lu, V. Chen, 2019, International Journal of Radiation Oncology*Biology*Physics.

Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer

H. Choy, R. Komaki, K. Bae, 2009 .

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

W. Sause, J. Cox, R. Komaki, 2000, International journal of radiation oncology, biology, physics.

Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer.

W. Curran, E. Gressen, A. Topham, 2000, American journal of clinical oncology.

Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas

James J. Evans, D. Andrews, K. Judy, 2015, Journal of Neurological Surgery—Part B.

Acoustic Neuromas and Other Benign Tumors: Fractionated Stereotactic Radiotherapy Perspective

D. Andrews, G. Bednarz, B. Downes, 2008 .

High KI67 Labeling Index in Resected WHO Grade 1 Meningiomas Correlates With a Higher Rate of Recurrence

D. Andrews, K. Judy, W. Shi, 2016 .

Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.

Jocelyn A Andrel, W. Curran, T. Showalter, 2007, International journal of radiation oncology, biology, physics.

Stupp the Wolf.

M. Werner-wasik, B. Greenberger, M. Werner-Wasik, 2021, International journal of radiation oncology, biology, physics.

Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

James J. Evans, Isabella Zhang, D. Andrews, 2018, Journal of Neuro-Oncology.

A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

W. Curran, K. Camphausen, T. Hyslop, 2011, Cancer.

Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC.

B. Leiby, A. Argiris, R. Zinner, 2020 .

Resected WHO grade I meningioma and predictors of local control

D. Andrews, K. Judy, J. Palmer, 2021, Journal of Neuro-Oncology.

Preservation of cranial nerve function after treatment of acoustic neurinomas with fractionated stereotactic radiotherapy. Preliminary observations in 26 patients.

D. Andrews, B. Downes, B. Corn, 1995, Stereotactic and functional neurosurgery.

Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss.

J. Sonke, J. Lebesque, A. Hope, 2019, Radiotherapy and Oncology.

Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: report of a prospective trial.

N. Simone, P. Anné, Joshua Siglin, 2015, Practical radiation oncology.

Disparity in age at lung cancer diagnosis between current and former smokers

V. Bar-ad, I. Chervoneva, Yinzhi Lai, 2019, Journal of Cancer Research and Clinical Oncology.

Radiosurgery for the treatment of dominant hemisphere periventricular heterotopia and intractable epilepsy in a series of three patients

James J. Evans, M. Sperling, A. Sharan, 2012, Epilepsy & Behavior Case Reports.

What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom.

Kristin D. Brockway, J. Piper, Ying Xiao, 2012, International journal of radiation oncology, biology, physics.

Brain and Spinal Cord

Susan M. Chang, D. Brat, M. Prados, 2017 .

Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration.

B. Movsas, C. Langer, M. Werner-Wasik, 2005, Seminars in oncology.

Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma

W. Curran, M. Werner-wasik, P. Gilman, 2011, Radiation oncology.

B3-07: A phase II study of Cetuximab (C225) in combination with chemoradiation

W. Curran, H. Choy, R. Komaki, 2007 .

A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214.

H. Choy, L. Gaspar, K. Bae, 2009, Journal of Clinical Oncology.

Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment.

P. Porcu, W. Shi, Joya Sahu, 2019, Chinese clinical oncology.

Spine Stereotactic Body Radiation Therapy Residual Setup Errors and Intra-Fraction Motion Using the Stereotactic X-Ray Image Guidance Verification System

Nicholas G Zaorsky, A. Dicker, D. Andrews, 2014, International journal of medical physics, clinical engineering and radiation oncology.

Combining stereotactic angiography and 3D time-of-flight magnetic resonance angiography in treatment planning for arteriovenous malformation radiosurgery.

G. Bednarz, B. Downes, R. Rosenwasser, 2000, International journal of radiation oncology, biology, physics.

Future development of amifostine as a radioprotectant.

M. Werner-Wasik, 1999, Seminars in oncology.

Nasopharyngeal carcinoma in children.

J. Goldwein, A. Uri, M. Werner-Wasik, 1996, Medical and pediatric oncology.

A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Glioblastoma Based Upon Multiplatform Biomarker Profiles

K. Aldape, W. Curran, Meihua Wang, 2012 .

431 A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Glioblastoma Based Upon Multi-Platform Biomarker Profiles

K. Aldape, W. Curran, Meihua Wang, 2012 .

Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients

James J. Evans, D. Andrews, K. Judy, 2019, American journal of clinical oncology.

Phase I Study of Ipilimumab Combined with Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients with Brain Metastases

James J. Evans, T. Olencki, A. Dicker, 2018 .

Evaluation of Elekta 4D cone beam CT-based automatic image registration for radiation treatment of lung cancer.

Yan Yu, Jun Li, Ying Xiao, 2015, The British journal of radiology.

Stereotactic image-guided lung radiotherapy (SBRT) for clinical early-stage NSCLC: A long-term report from a multi-institutional database of patients treated with or without a pathologic diagnosis.

L. Kestin, A. Hope, I. Grills, 2019, Practical radiation oncology.

A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy

J. Sonke, D. Yan, L. Kestin, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.

M. Roach, R. Byhardt, C. Scott, 1999, International journal of radiation oncology, biology, physics.

Final Report of a Pilot Study of Carboplatin Plus Dose Dense Pemetrexed and Radiotherapy for Locally-advanced Non–small-cell Lung Carcinoma

W. Curran, P. Gilman, R. Axelrod, 2009 .

Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery

Bo Lu, Yan Yu, Maria Werner-Wasik, 2016, Technology in cancer research & treatment.

Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy.

W. Curran, W. Hauck, M. Werner-wasik, 2001, Clinical lung cancer.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.

James J. Evans, W. Curran, K. Camphausen, 2014, International journal of radiation oncology, biology, physics.

Predictors and characteristics of Rib fracture following SBRT for lung tumors

B. Sundaram, G. Kane, B. Greenberger, 2023, BMC Cancer.

Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.

D. Andrews, M. Downes, W. Curran, 2004, Neurosurgery.

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424

B. Fisher, D. D'Souza, D. Macdonald, 2020 .

NRG Oncology/RTOG 0937: Randomized Phase 2 Study Comparing Prophylactic Cranial Irradiation (PCI) Alone to PCI and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

R. Hales, P. Iyengar, J. Bradley, 2016 .

A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (pts) with stage III A/B non-small cell lung cancer (NSCLC): An interim report of the RTOG 0324 trial

W. Curran, H. Choy, R. Komaki, 2005 .

ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA)

Susan M. Chang, K. Aldape, D. Brachman, 2015 .

Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA).

Susan M. Chang, K. Aldape, D. Brachman, 2015 .

A phase I trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

W. Curran, A. Dicker, A. Lin, 2008 .

Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy.

James J. Evans, J. Galvin, T. Hyslop, 2008, Medical physics.

Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial.

R. Castillo, E. Castillo, T. Guerrero, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Atypical and malignant meningiomas: an outcome report of seventeen cases

B. Corn, W. Curran, C. Coke, 1998, Journal of Neuro-Oncology.

PET Tumor Segmentation: Multi-observer Validation of a Gradient-Based Method using a NSCLC PET Phantom

J. Piper, A. Nelson, W. Choi, 2009 .

Randomized trial of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): Long-term survival results of Radiation Therapy Oncology Group (RTOG) 9801

Benjamin Movsas, Nicos Nicolaou, R. Komaki, 2007 .

Randomized prospective comparison of stereotactic radiosurgery (SRS) followed by conventional radiotherapy (RT) with BCNU to RT with BCNU alone for selected patients with supratentorial glioblastoma multiforme (GBM): report of RTOG 93-05 protocol

P. Okunieff, W. Curran, D. Brachman, 2002 .

Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab

P. Fortina, Nicholas G Zaorsky, A. Dicker, 2013, Cancer biology & therapy.

Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma

H. Madoc‐Jones, M. Werner-wasik, C. Schmid, 1995, Cancer.

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

K. Aldape, W. Curran, D. Brachman, 2014, The New England journal of medicine.

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

James J. Evans, D. Andrews, J. Palmer, 2014, Journal of Neuro-Oncology.

Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.

A. Alavi, J. Bradley, B. Siegel, 2015, Journal of the National Cancer Institute.

Fractionated Stereotactic Radiotherapy For the Treatment of Large Arteriovenous Malformations with or without Previous Partial Embolization

D. Andrews, M. Downes, W. Curran, 2004, Neurosurgery.

The Influence of Health Insurance Policy on Radiation Oncology Physician SBRT/SABR Use Practices: A North American Survey.

Tu D. Dan, Hyun Kim, Jenny Guo, 2017, International journal of radiation oncology, biology, physics.

The American Society for Radiation Oncology's 2010 core physics curriculum for radiation oncology residents.

I. Chetty, J. Palta, B. Paliwal, 2011, International journal of radiation oncology, biology, physics.

Genetic landscape of extreme responders with anaplastic oligodendroglioma

M. Mehta, K. Kinzler, C. Bettegowda, 2017, Oncotarget.

A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

W. Curran, K. Camphausen, T. Hyslop, 2011, Cancer.

Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy

M. Werner-Wasik, A. Dicker, W. Choi, 2024, JCO clinical cancer informatics.

H. Choy, R. Komaki, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Implementation and experimental results of 4D tumor tracking using robotic couch.

T. Podder, Y. Yu, Ivan Buzurovic, 2012, Medical physics.

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

J. Flickinger, M. Gilbert, M. Mehta, 2021, Journal of Neuro-Oncology.

Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.

J. Sonke, L. Kestin, I. Grills, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Scalp-sparing radiation with concurrent temozolomide and tumor treating fields (SPARE) for patients with newly diagnosed glioblastoma.

D. Andrews, K. Judy, V. Bar-ad, 2021 .

Dosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcs.

Evangelos Pappas, Maria Werner-Wasik, Yan Yu, 2016, Journal of applied clinical medical physics.

Dosimetric validation for an automatic brain metastases planning software using single‐isocenter dynamic conformal arcs

James J. Evans, Yan Yu, Jun Li, 2016, Journal of applied clinical medical physics.